Similar potentiation of the cytotoxic effect of doxorubicin by WIP1 inhibition has recently been reported in neuroblastoma cells and in a colorectal carcinoma cells with a C-terminally truncated PPM1D [61, 64]. The gene discussed is PPM1D; the disease is neuroblastoma.